PATENT CLAIM ANALYSIS

Application Number: 16055565
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["424", "248100"]

Abstract:
The invention provides methods and compositions for treating fibromyalgia (FM) and chronic fatigue syndrome (CFS) in an individual. The methods provided herein entail administering a composition comprising an isolated  Mycobacterium  or antigenic fragments derived therefrom. Also provided herein are methods for assessing alleviation of symptoms and/or alteration of immune system functioning following administration of a composition comprising an isolated  Mycobacterium  or antigenic fragments derived therefrom.

Claim (Index 6):
The method of  claim 4 , wherein the BCG strain is a sub-strain selected from BCG Pasteur (1961), BCG Moreau, BCG Tokyo, BCG Russia (1924), BCG Japan (1925), BCG Sweden (1927), BCG Birkhaug, BCG Prague, BCG Glaxo (1954), BCG Merieux (1989), BCG Danish, BCG Frappier, BCG Connaught (1948), BCG Mexico, BCG Tice (1934), BCG China or BCG Phipps.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 96.0
- Lexical Diversity: 1.53191
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11838631', '15061201', '09374142', '13761092', '13387096']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6570847001847326
- 35 USC 102 Novelty (BERT): 0.5011617596729766
- Combined Prediction Score: 0.6414924061335571
- Mean Citation Score: 199.16087
- Max Citation Score: 203.08032
- Similarity Product: 136.64366110588074

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test